Peter R. Rose
18Patents
2h-index
43Co-inventors
54Inventor score
Filing activity: Oct 7, 1996 → Oct 21, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6890927B2 | Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof | Human Necessities | 17 | Expired |
| US7265119B2 | Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof | Human Necessities | 11 | Expired |
| US6787549B2 | Citrate salt of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof | Human Necessities | 2 | Expired |
| US6387925B1 | Polymorphs of a crystalline azo-bicyclo (2.2.2) oct-3-yl amine citrate and their pharmaceutical compositions | Human Necessities | 2 | Expired |
| US5929240A | Process and intermediates for preparing naphthyridonecarboxylic acid salts | Chemistry; Metallurgy | 1 | Expired |
| US6541634B2 | Process for preparing growth hormone secretagogues | Emerging Cross-Sectional Technologies | 1 | Expired |
| US11299500B2 | Crystalline form of lorlatinib free base hydrate | Chemistry; Metallurgy | 1 | Active |
| US6673929B2 | Process for preparing growth hormone secretagogues | Emerging Cross-Sectional Technologies | 1 | Expired |
| US12116368B2 | Pyrrolo[2,3-d]pyrimidine tosylate salt, crystalline form thereof and manufacturing process and intermediates thereto | Chemistry; Metallurgy | 0 | Active |
| US9056831B2 | Process for forming amorphous atorvastatin | Human Necessities | 0 | Active |
| US7285686B2 | Process for the preparation of 1,3-substituted indenes | Human Necessities | 0 | Expired |
| US6573383B2 | Preparation of anhydrous CETP inhibitor | Human Necessities | 0 | Expired |
| US6359137B1 | Process for preparing trovafloxacin acid salts | Chemistry; Metallurgy | 0 | Expired |
| US6683106B2 | N-(indole-2-carbonyl)-b-alaninamide crystal forms | Chemistry; Metallurgy | 0 | Expired |
| US8258315B2 | Process for forming amorphous atorvastatin | Human Necessities | 0 | Active |
| US8026376B2 | Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoicacid calcium salt (2:1) | Human Necessities | 0 | Active |
| US6013808A | Method of purifying carbazole ester precursors of 6-chloro-.alpha.-methyl-carbazole-2-acetic acid | Chemistry; Metallurgy | 0 | Expired |
| US6696574B2 | Processes and intermediates for preparing glycogen phosphorylase inhibitors | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.